(ONO) onesano S.A. - Ratings and Ratios

onesano S.A. is a Polish company specializing in research and development across dietetics, animal nutrition, bioremediation, and agrotechnological processes. The company has a diverse product portfolio, including human dietary supplements under the Estrovita brand, as well as Yarrowia Equinox, Yarrowia Canifelox, and Yarrowia Farminox products. These offerings cater to various markets, including human health supplements, animal nutrition, and cosmetic raw materials, distributed through a broad network of chain pharmacies, wholesalers, e-commerce platforms, and veterinary offices.

With a history dating back to 1995, originally as Skotan SA before rebranding to onesano S.A. in March 2023, the company has established a strong presence in Poland and potentially beyond. The shift in name may indicate a strategic reorientation or expansion of its business scope. The companys product range and distribution channels suggest a robust operational framework, leveraging both traditional retail and modern e-commerce channels.

Analyzing the provided , the stocks current price is 0.91 PLN, below its short-term moving averages (SMA20 at 1.01 and SMA50 at 1.00), indicating a potential bearish trend or a consolidation phase. The Average True Range (ATR) of 0.07 (or 7.73%) suggests moderate volatility. Given the 52-week high of 1.30 PLN and low of 0.91 PLN, the stock is currently at its 52-week low, potentially signaling undervaluation or a downturn in investor sentiment.

Considering the , onesano S.A.s market capitalization stands at 65.62M PLN. The absence of P/E ratios and Return on Equity (RoE) data may indicate either a lack of profitability or the companys financials not being up-to-date. For a comprehensive analysis, further financial metrics and recent performance data would be necessary.

Forecasting based on the available data, if onesano S.A. can demonstrate a return to profitability and improve its financial health, the stock might attract more investors. Technically, a break above the SMA20 and SMA50 levels could signal a bullish trend, potentially driving the price towards the 52-week high of 1.30 PLN. Conversely, failure to regain these levels might lead to further consolidation or a decline. Investors should closely monitor the companys financial releases and industry trends for a more informed investment decision.